Finance

Lists
Why is 300026 up 2.22%?
Dive Deeper
300026:SHE
Tianjin Chase Sun Pharmaceutical Co Ltd
CNÂ¥3.23
+2.22%
(+0.070) 1D
Nov 4, 3:04:46 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300026...
Open
CNÂ¥3.16
High
CNÂ¥3.24
Low
CNÂ¥3.16
Mkt. cap
9.49B
Avg. vol.
38.54M
Volume
50.34M
Dividend
0.31%
Quarterly dividend
CNÂ¥0.00
Ex-dividend date
Jul 15, 2026
P/E ratio
376.90
52-wk high
CNÂ¥3.99
52-wk low
CNÂ¥2.82
EPS
CNÂ¥0.01
Shares outstanding
3.00B
No. of employees
5K
Open
CNÂ¥3.16
High
CNÂ¥3.24
Low
CNÂ¥3.16
Mkt. cap
9.49B
Avg. vol.
38.54M
Volume
50.34M
Dividend
0.31%
Quarterly dividend
CNÂ¥0.00
Ex-dividend date
Jul 15, 2026
P/E ratio
376.90
52-wk high
CNÂ¥3.99
52-wk low
CNÂ¥2.82
EPS
CNÂ¥0.01
Shares outstanding
3.00B
No. of employees
5K
News stories
From web sources and news partners
About Tianjin Chase Sun Pharmaceutical Co Ltd
CEO-
Employees4.85K
Founded1996
Headquarters-
SectorPharmaceutical industry
Industry-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
792.56M
1.13B
1.06B
918.33M
Cost of goods sold
210.74M
481.15M
489.63M
369.44M
Cost of revenue
210.74M
481.15M
489.63M
369.44M
Research and development expenses
59.53M
45.15M
38.46M
40.24M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
545.90M
487.36M
488.56M
461.31M
Operating expense
629.26M
557.39M
536.60M
497.12M
Total operating expenses
840.00M
1.04B
1.03B
866.56M
Operating income
-47.44M
91.69M
31.50M
51.76M
Other non operating income
-8.94M
-2.84M
3.03M
-11.57M
EBT including unusual items
-58.55M
84.27M
23.16M
17.39M
EBT excluding unusual items
-61.38M
87.15M
29.53M
46.88M
Income tax expense
11.15M
15.65M
8.87M
6.07M
Effective tax rate
-19.04%
18.57%
38.30%
34.91%
Other operating expenses
28.18M
10.63M
13.82M
5.57M
Net income
-62.27M
65.71M
12.37M
9.95M
Net profit margin
-7.86%
5.81%
1.17%
1.08%
Earnings per share
-
-
-
-
Interest and investment income
2.64M
2.22M
2.40M
6.93M
Interest expense
-4.90M
-3.91M
-3.02M
-4.61M
Net interest expenses
-2.26M
-1.69M
-623.06K
2.31M
Depreciation and amortization charges
-
-
-
-
EBITDA
20.83M
159.96M
98.09M
120.04M
Gain or loss from assets sale
-702.54K
-
-11.04K
11.04K
Upcoming events
AI content may include mistakes. Learn more
Google apps